Cite Filings / DMRA / 0001193125-25-269426
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Damora Therapeutics, Inc. · Filed 2025-11-06 · Acc 0001193125-25-269426

Documents 1

  • 10-Q Quarterly Report , glto-20250930.htm

Around this filing

  • 2026-05-12 10-Q Quarterly Report
  • 2025-11-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-11-10 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  • 2025-11-06 10-Q Quarterly Report
  • 2025-08-05 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading glto-20250930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…